Fecal transplant to prevent infections after liver transplant
Treatments studied
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study tests if giving a fecal transplant (a procedure that transfers healthy bacteria from a donor's stool into your gut) before a liver transplant can lower the risk of serious infections after the surgery. It might help strengthen your immune system to fight off germs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and scheduled to receive a liver transplant.
- You have not had your entire colon removed.
- You are not pregnant or breastfeeding.
- You are not currently taking antibiotics by mouth or through an IV.
- You do not have an active COVID-19 infection.
- You do not have a severe allergy to macrogol (a laxative used in bowel prep for colonoscopy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a fecal transplant (transferring healthy bacteria from a donor into your gut) can improve bowel control problems that sometimes happen after rectal cancer surgery. If you have ongoing trouble with leakage or urgency, this treatment might help.
This study tests if a fecal transplant (putting healthy donor stool into your gut) can help people who keep having serious liver-related brain problems after a TIPS procedure, even with standard medicines. It might restore a healthier balance of gut bacteria.
This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.
This trial studies whether transferring healthy gut bacteria (from a donor sample) can improve outcomes for people with liver cirrhosis who have worsening complications. It may help by changing the gut microbiome, which can influence inflammation and liver health.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This trial tests whether transplanting healthy gut bacteria (from donor stool) can improve outcomes in people with cirrhosis. If you have mild to moderate cirrhosis, you may be able to join.
Hear when a new Fecal Microbiota Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.